MedTrace Logo

Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

NCT02568202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 449

Last updated 2016-01-12

No results posted yet for this study

Summary

This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).

Conditions

  • Haemostasis
  • Congenital Bleeding Disorder
  • Haemophilia B

Interventions

OTHER

No treatment given

This is an online web-based cross-sectional survey in which participants will complete one of two questionnaires. There will be no treatment.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02568202 on ClinicalTrials.gov